Supplement improves vascular health markers

A clinical investigation has revealed that daily consumption of the Novos Core supplement led to observable improvements in vascular health indicators after a six-month period. The formulation combines specific vitamins, minerals, essential amino acids, and plant-based compounds designed to influence biological mechanisms linked to aging.

Conducted by University of Surrey researchers, the trial tracked 61 volunteers, 33 receiving the supplement and 28 given a placebo, while monitoring key cardiovascular metrics. The study determined that Novos Core enhanced endothelial function, reduced arterial stiffness, and lowered systolic blood pressure, with effects detectable within just one hour of initial administration.

The researchers emphasized that the measured biomarkers reflect interconnected aspects of vascular health tied to cardiovascular risk factors, rather than direct clinical outcomes. According to Christian Heiss, professor of Cardiovascular Medicine at the University of Surrey, aging involves multiple interacting biological pathways rather than a single process.

Christian Heiss noted the study examined whether a single nutritional intervention could simultaneously influence several of these pathways, producing detectable changes in vascular health markers. Instead of focusing on clinical events, the team prioritized well-established indicators such as blood pressure and arterial function.

Published in European Heart Journal Open, the results showed participants using Novos Core experienced greater flow-mediated dilation, a key measure of endothelial health, compared to the placebo group. After six months, the supplement group’s systolic blood pressure averaged 6.1 mmHg lower than the placebo group, even after statistical adjustments.

Previous research has shown that a 5 mmHg sustained reduction in systolic pressure correlates with roughly a 10% lower risk of major cardiovascular incidents over time. The study also found that pulse wave velocity, a marker of arterial stiffness, was reduced by 1.18 m/s in the supplement group relative to controls after six months.

While participants’ projected 10-year cardiovascular risk showed a modest decline, primarily due to blood pressure improvements, the researchers highlighted the need for further investigation.